GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (TSX:MBX) » Definitions » Scaled Net Operating Assets

Microbix Biosystems (TSX:MBX) Scaled Net Operating Assets : 0.59 (As of Dec. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Microbix Biosystems Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Microbix Biosystems's operating assets for the quarter that ended in Dec. 2024 was C$26.25 Mil. Microbix Biosystems's operating liabilities for the quarter that ended in Dec. 2024 was C$3.96 Mil. Microbix Biosystems's Total Assets for the quarter that ended in Sep. 2024 was C$38.10 Mil. Therefore, Microbix Biosystems's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.59.


Microbix Biosystems Scaled Net Operating Assets Historical Data

The historical data trend for Microbix Biosystems's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbix Biosystems Scaled Net Operating Assets Chart

Microbix Biosystems Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.65 1.05 0.60 0.59 0.61

Microbix Biosystems Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 0.59 0.57 0.58 0.59

Competitive Comparison of Microbix Biosystems's Scaled Net Operating Assets

For the Biotechnology subindustry, Microbix Biosystems's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microbix Biosystems's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Microbix Biosystems's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Microbix Biosystems's Scaled Net Operating Assets falls into.



Microbix Biosystems Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Microbix Biosystems's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Sep. 2024 )
=(Operating Assets (A: Sep. 2024 )-Operating Liabilities (A: Sep. 2024 ))/Total Assets (A: Sep. 2023 )
=(25.134-3.402)/35.653
=0.61

where

Operating Assets(A: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=38.097 - 12.963
=25.134

Operating Liabilities(A: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=9.799 - 6.155 - 0.242
=3.402

Microbix Biosystems's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2024 )
=(Operating Assets (Q: Dec. 2024 )-Operating Liabilities (Q: Dec. 2024 ))/Total Assets (Q: Sep. 2024 )
=(26.251-3.957)/38.097
=0.59

where

Operating Assets(Q: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=39.299 - 13.048
=26.251

Operating Liabilities(Q: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=10.399 - 6.22 - 0.222
=3.957

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Microbix Biosystems Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Microbix Biosystems's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Microbix Biosystems Business Description

Traded in Other Exchanges
Address
265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and; Development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.
Executives
James Stuart Currie Senior Officer
Mark Adrian Luscher Senior Officer
Bo Hollas Director
Jennifer Anne Stewart Director
Cameron Lionel Groome Director, Senior Officer
Kenneth Hughes Senior Officer
Martin Marino Director
Peter Martin Blecher Director
Philip Jonathan Casselli Senior Officer
Steven Trevor Hagerman Senior Officer
Damian Klimaszewski Senior Officer
Anthony J. Giovinazzo Director